Voprosy praktičeskoj pediatrii

Efficacy and safety of a combination of two monoclonal antibodies against SARS-CoV-2 (tixagevimab/cilgavimab) in the pre-exposure prevention of novel coronavirus infection in immunocompromised pediatric patients with rheumatic diseases. Preliminary results of the first prospective observational cohort study in the Russian Federation

Pub Date : 2023-01-01 DOI: 10.20953/1817-7646-2023-1-16-26 M.Yu. Kokina, D.S. Fomina, M.S. Lebedkina, Z.Yu. Mutovina, E.S. Zholobova, S.Kh. Kurbanova, A.K. Nargizyan, A.N. Fetisova, A.E. Angel, T.M. Dvoryakovskaya, I.Yu. Shilkrot, E.I. Alexeeva